CN1347731A - Externally applied Chinese medicine prepn for treating lumbar vertebra disease - Google Patents
Externally applied Chinese medicine prepn for treating lumbar vertebra disease Download PDFInfo
- Publication number
- CN1347731A CN1347731A CN 01137212 CN01137212A CN1347731A CN 1347731 A CN1347731 A CN 1347731A CN 01137212 CN01137212 CN 01137212 CN 01137212 A CN01137212 A CN 01137212A CN 1347731 A CN1347731 A CN 1347731A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- lumbar vertebra
- treatment
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The externally used Chinese medicine preparation is prepared with notoperygium root, Achyranthes bidentate, Radix aconiti, notoginseng, frankincense and other Chinese medicinal materials. it is dressed to the affected part, acts through transdermal absorption, and has specific effect on lumbar vertebra disease. It may be also used in treating hyperosteogeny, cervical spondylopathy, scapulohumeral periarthritis, hyperplastic knee arthritis, various soft tissue damage and injury caused by strain and sprain. It can stop pain, diminish swelling, promote blood circulation to disperse blood clots, eliminate wind evil and eliminate inflammtion.
Description
Technical field
The present invention relates to a kind of Traditional Chinese Medicine for external application preparation, especially relate to a kind of Chinese medicine for outer use of the lumbar vertebra hemiplegia disease that to be the raw material treatment made from the Chinese herbal medicine cause because of hyperosteogeny.
Background technology
Hyperosteogeny is a kind of common frdquently encountered disease, according to WHO statistics, suffer from the hyperosteogeny patient and account for 10% of total population, China 40-60 year middle-aged and elderly people 90% all suffer from hyperosteogeny.Hyperosteogeny is by the soft tissue degeneration or after being subjected to wound and a kind of cervical vertebra, hyperosteogeny, the osteoarthrosis illness that cause, belong to the traditional Chinese medical science " rheumatism involving the bone ", " arthromyodynia " category.Divide cervical spondylosis, lumbar spondylosis, gonarthrosis according to the difference of disease sites, wherein lumbar spondylosis is common especially, because bony spur length is at the lumbar vertebra position, neural, the tremulous pulse of the compressing spinal cord or the back of the body, this sick clinical manifestation is the waist limitation of activity, bends over, upright difficulty general lumbar vertebra 2 to 5 vertebra spinous process tenderness and companion's intervertebral disk hernia, when reaching serious, can cause lateral bending lumbar vertebra hemiplegia, aching and weakness, activity are obstructed, even cause deformity, be difficult to radical cure, medically be considered as one of refractory disease.In the existing therapy to this disease, operative therapy not only has certain risk and expense costliness, and the bony spur that also can regrow after the treatment; The oral drugs therapy is treated this sick Chinese patent medicine and common yeast for brewing rice wine as some, and certain curative effect is arranged, but the intestines and stomach is stimulated greatly, and the patient is difficult to accept; Western medicine contains a large amount of morphines and hormone mostly, and life-time service has destruction to cartilage.
Summary of the invention
The object of the present invention is to provide that a kind of stable curative effect and flavour of a drug are less, the Traditional Chinese Medicine for external application preparation blood stasis dispelling sclerotin of the treatment lumbar spondylosis of reasonable mixture ratio looses.
The present invention acts on the affected part by topical, and the dermal osmosis therapy has been avoided the bad reflection of oral drugs.Rapidly pain relieving, subside a swelling, invigorate blood circulation, diminish inflammation, again can treating both the principal and secondary aspects of a disease, not only economical, convenient but also curative effect is fast.
The present invention is achieved through the following technical solutions:
The inventor is according to the differential diagnosis in tcm medical knowledge, on the basis of secret prescription handed down in the family from generation to generation, again in conjunction with clinical practice for many years, the lumbar spondylosis that causes because of hyperosteogeny has been carried out deep research, think that this disease is due to wound, the stasis of blood, the wind, be related again each other, so propose: blood circulation promoting and blood stasis dispelling, cure the wound dispel the wind, relaxing muscles and tendons and activating QI and blood in the collateral, the Therapeutic Principle that anti-nuclear disappears thorn selects for use the Chinese medicine composition powder to be mixed into Chinese medicine for outer use blood stasis dispelling sclerotin and looses.
A kind of diffusing Chinese medicine for outer use of blood stasis dispelling sclerotin that is used for the treatment of lumbar spondylosis is characterized in that it is that raw material is made (consumption is weight portion) by the component of following proportioning
Rhizoma Et Radix Notopterygii 1-3 Radix Aconiti Kusnezoffii 1-2 Radix Achyranthis Bidentatae 1-3
Radix Angelicae Pubescentis 1-3 Rhizoma Sparganii 1-3 Sanguis Draxonis 1-3
Radix Aconiti 1-2 FENGSHU 1-3 Radix Notoginseng 1-3
Flos Carthami 1-3 Myrrha 1-3 acid bar 1-3
Specific implementation method
Describe the present invention below with reference to embodiment:
Prescription is: (consumption is weight portion)
Rhizoma Et Radix Notopterygii 2 Radix Aconiti Kusnezoffii 1.5 Radix Achyranthis Bidentataes 2 Radix Angelicae Pubescentiss 2
Rhizoma Sparganii 2 Sanguis Draxonis 2 Radix Aconitis 1.5 FENGSHU 2
Radix Notoginseng 2 Flos Carthamis 2 Myrrhas 2 sour bars 2
Above each medicine mixing is ground into superfine powder constituent medicine cake.During treatment, apply in the patient's waist affected part, twenty four hours is changed dressings cake once, and the drug of topical application one month was a course of treatment continuously.General disease the lighter only need treat a course of treatment, pain relief after the drug of topical application 5 times, and after the course of treatment, therapeutic effect is remarkable, and life can take care of oneself.The heavy person of disease needs the continuous drug of topical application 90 times, i.e. three courses of treatment, generally equal the healing.
Prescription compatibility foundation of the present invention (according to the Compendium of Material Medica record): Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis: its effect is dispersed for dispeling the wind; Rhizoma Sparganii, FENGSHU: its effect is the clots absorbing thorn that disappears; Radix Achyranthis Bidentatae, Sanguis Draxonis: its effect is a promoting blood circulation to remove obstruction in the collateral; Radix Aconiti, Radix Aconiti Kusnezoffii: its effect is hindered blood stasis dispelling for dispelling; Radix Notoginseng: its effect is a nourishing blood and promoting blood circulation; Flos Carthami: its effect is a blood stasis removing and clots absorbing; Olibanum, Myrrha: its effect is hindered blood stasis dispelling for dispelling.Above compatibility, its preparation (medicine cake) is had: blood circulation promoting and blood stasis dispelling, dispel the wind and cure the wound, relaxing muscles and tendons and activating QI and blood in the collateral, anti-nuclear disappear thorn, anti-inflammatory analgesic, improve blood circulation, can promote lumbar vertebrae bone to soften atrophy, be used for the treatment of lumbar spondylosis, have specially good effect, also can be used for treating hyperosteogeny, cervical spondylosis, scapulohumeral periarthritis, joint hyperplasia arthritis and all kinds of soft tissue injury, impairment caused by overstrain.
The present invention thinks according to clinical discussion for many years: the treatment of lumbar spondylosis should be started with from wound, the stasis of blood, wind, the beginning of all kinds of diseases and ailments, and after wound, the stasis of blood, the eolian heresy, can cause human body new pathological process to occur, produce many diseases, so there are all kinds of diseases and ailments to have the stasis of blood to stage an armed rebellion more.In lumbar disc disease, mostly be stasis of blood turmoil greatly, show as numbness and ache, according to clinical manifestation, list can be divided into the tangible stasis of blood, the invisible stasis of blood shows as the dysfunction of additivity mostly, as sclerotin evolutions such as lumbar vertebra root compressions, about pathogenic factor, be that the waist blood operation is not smooth, progressively stage an armed rebellion, cause neural ischias, and the lumbar vertebra blood circulation is obstructed.Therefore the present invention is on the basis of secret prescription handed down in the family from generation to generation, determine through a large amount of experiment screenings, each composition of Quan Fangzhong supplements and complements each other, focus on blood circulation promoting and blood stasis dispelling, cure the wound dispel the wind, anti-inflammatory analgesic, anti-nuclear disappear thorn, active passages through which vital energy circulates, thereby reach the effect that the promotion lumbar vertebra bone spur is dissolved.
Points for attention of the present invention: child, contraindication in pregnancy; External only, not oral administration.
Claims (2)
1, a kind of Chinese medicine for outer use blood stasis dispelling sclerotin for the treatment of lumbar spondylosis looses, and it is characterized in that it is that raw material is made (consumption is weight portion) by the component of following proportioning
Rhizoma Et Radix Notopterygii 1-3 Radix Aconiti Kusnezoffii 1-2 Radix Achyranthis Bidentatae 1-3
Radix Angelicae Pubescentis 1-3 Rhizoma Sparganii 1-3 Sanguis Draxonis 1-3
Radix Aconiti 1-2 FENGSHU 1-3 Radix Notoginseng 1-3
Flos Carthami 1-3 Myrrha 1-3 acid bar 1-3
2, a kind of Chinese medicine for outer use blood stasis dispelling sclerotin for the treatment of lumbar spondylosis according to claim 1 looses, and it is characterized in that described each amounts of components is (consumption is weight portion)
Rhizoma Et Radix Notopterygii 2 Radix Aconiti Kusnezoffii 1.5 Radix Achyranthis Bidentataes 2 Radix Angelicae Pubescentiss 2
Rhizoma Sparganii 2 Sanguis Draxonis 2 Radix Aconitis 1.5 FENGSHU 2
Radix Notoginseng 2 Flos Carthamis 2 Myrrhas 2 sour bars 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01137212 CN1347731A (en) | 2001-10-22 | 2001-10-22 | Externally applied Chinese medicine prepn for treating lumbar vertebra disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01137212 CN1347731A (en) | 2001-10-22 | 2001-10-22 | Externally applied Chinese medicine prepn for treating lumbar vertebra disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1347731A true CN1347731A (en) | 2002-05-08 |
Family
ID=4674095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01137212 Pending CN1347731A (en) | 2001-10-22 | 2001-10-22 | Externally applied Chinese medicine prepn for treating lumbar vertebra disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1347731A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104645240A (en) * | 2015-03-05 | 2015-05-27 | 向成东 | Traditional Chinese medicine preparation for relieving pain and preparation method of traditional Chinese medicine preparation |
| CN107198761A (en) * | 2017-05-11 | 2017-09-26 | 赢进珍 | A kind of rapidly-soluble medicinal liquor and preparation method thereof |
-
2001
- 2001-10-22 CN CN 01137212 patent/CN1347731A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104645240A (en) * | 2015-03-05 | 2015-05-27 | 向成东 | Traditional Chinese medicine preparation for relieving pain and preparation method of traditional Chinese medicine preparation |
| CN104645240B (en) * | 2015-03-05 | 2018-06-15 | 向成东 | A kind of Chinese medicine analgetic preparation and preparation method thereof |
| CN107198761A (en) * | 2017-05-11 | 2017-09-26 | 赢进珍 | A kind of rapidly-soluble medicinal liquor and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100376276C (en) | Soothe tendons and activating-blood anodyne plaster | |
| CN1255172C (en) | Medical paste for rheumatism and bone ache | |
| CN103006962A (en) | Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation | |
| CN101234153B (en) | Externally-applied medicament for treating bone fracture | |
| CN1237427A (en) | Adhesive plaster for curing prolapse of lumbar intervertebral disk | |
| CN102309723A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN1403141A (en) | Plaster for treating cervical spondylosis and lumbar vertebra disease | |
| CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN100396316C (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN101912458B (en) | Medicament for treating protrasion of the lumbar intervertebral disci | |
| CN1347731A (en) | Externally applied Chinese medicine prepn for treating lumbar vertebra disease | |
| CN102319316B (en) | Rapid bone hyperplasia healing agent | |
| CN101057957A (en) | External applied traditional Chinese medicine lotion for treating osteoproliferation and bony spur | |
| CN105012908A (en) | Traditional Chinese medicine preparation for treating strain of lumbar muscles | |
| CN1267127C (en) | Osteoproliferation medicine for external application | |
| CN1850238A (en) | Medicine composition for treating backbone and joint disease | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN102228528B (en) | Chinese medicinal preparation for treating arthritis | |
| CN105560537A (en) | Medicine composition for treating osteoartritis and preparation method thereof | |
| CN1899346A (en) | Bighead atractylodes rhizome spine ache tablet | |
| CN1175852C (en) | Medicine for treating hyperosteogeny | |
| CN1319408A (en) | Medicated liquor for treating traumatic injury | |
| CN1589859A (en) | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis | |
| CN1391939A (en) | External medicine for curing traumatic injuries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |